CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2005-03-16): US FDA, Biogen warn over multiple sclerosis drug

Regulatory

US FDA, Biogen warn over multiple sclerosis drug

Last Updated: 2005-03-16 16:00:20 -0400 (Reuters Health)

WASHINGTON (Reuters) - Biogen Idec's multiple sclerosis drug Avonex (interferon beta-1a) can cause severe liver injury, including liver failure, U.S. regulatory officials and the company warned on Wednesday.

"In some cases, these events have occurred in the presence of other drugs that have been associated with hepatic injury," the FDA and Biogen said in a statement posted to the agency's Web site. The company is revising the drug's label to include the new warning, the statement said.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.